Search Results - "Pokorny, Barbara A."

  • Showing 1 - 13 results of 13
Refine Results
  1. 1
  2. 2

    Gene constellation of influenza A virus reassortants with high growth phenotype prepared as seed candidates for vaccine production by Fulvini, Andrew A, Ramanunninair, Manojkumar, Le, Jianhua, Pokorny, Barbara A, Arroyo, Jennifer Minieri, Silverman, Jeanmarie, Devis, Rene, Bucher, Doris

    Published in PloS one (13-06-2011)
    “…Influenza A virus vaccines undergo yearly reformulations due to the antigenic variability of the virus caused by antigenic drift and shift. It is critical to…”
    Get full text
    Journal Article
  3. 3

    Molecular signature of high yield (growth) influenza a virus reassortants prepared as candidate vaccine seeds by Ramanunninair, Manojkumar, Le, Jianhua, Onodera, Shiroh, Fulvini, Andrew A, Pokorny, Barbara A, Silverman, Jeanmarie, Devis, Rene, Arroyo, Jennifer M, He, Yu, Boyne, Alex, Bera, Jayati, Halpin, Rebecca, Hine, Erin, Spiro, David J, Bucher, Doris

    Published in PloS one (11-06-2013)
    “…Human influenza virus isolates generally grow poorly in embryonated chicken eggs. Hence, gene reassortment of influenza A wild type (wt) viruses is performed…”
    Get full text
    Journal Article
  4. 4

    The Total Influenza Vaccine Failure of 1947 Revisited: Major Intrasubtypic Antigenic Change Can Explain Failure of Vaccine in a Post-World War II Epidemic by Kilbourne, Edwin D., Smith, Catherine, Brett, Ian, Pokorny, Barbara A., Johansson, Bert, Cox, Nancy

    “…Although vaccine-induced immunity to influenza A virus is continually challenged by progressively selected mutations in the virus's major antigens (antigenic…”
    Get full text
    Journal Article
  5. 5

    HA1 (Hemagglutinin) quantitation for influenza A H1N1 and H3N2 high yield reassortant vaccine candidate seed viruses by RP-UPLC by Fulvini, Andrew A., Tuteja, Akaash, Le, Jianhua, Pokorny, Barbara A., Silverman, Jeanmarie, Bucher, Doris

    Published in Vaccine (15-01-2021)
    “…The only effective measure to decrease morbidity and mortality caused by the influenza virus in the human population is worldwide vaccination. Vaccination…”
    Get full text
    Journal Article
  6. 6

    Protection of Mice with Recombinant Influenza Virus Neuraminidase by Kilbourne, Edwin D., Pokorny, Barbara A., Johansson, Bert, Brett, Ian, Milev, Youli, Matthews, James T.

    Published in The Journal of infectious diseases (01-02-2004)
    “…Contemporary influenza vaccines are standardized with respect to their content of hemagglutinin, the major virus antigen. Although the immunizing effect of…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Development of high yield reassortants for influenza type B viruses and analysis of their gene compositions by Le, Jianhua, Orff, Edward J, Fulvini, Andrew A, Huang, Liling, Onodera, Shiroh, Pokorny, Barbara A, Malewicz, Andrew, Primakov, Patricia, Bucher, Doris J

    Published in Vaccine (11-02-2015)
    “…Highlights • High yield (hy) reassortant influenza B seed viruses for vaccine production can be developed through classical reassortment of wild type (wt) B…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Supplementation of conventional trivalent influenza vaccine with purified viral N1 and N2 neuraminidases induces a balanced immune response without antigenic competition by Johansson, Bert E, Pokorny, Barbara A, Tiso, Vincent A

    Published in Vaccine (22-02-2002)
    “…Influenza viruses neuraminidase (NA) were chromatographically extracted from influenza viruses A/Nanchang/933/95 H3 NCN2 NC [R] and A/Johannesburg/82/96 H1…”
    Get full text
    Journal Article
  11. 11

    Molecular Signature of High Yield by Ramanunninair, Manojkumar, Le, Jianhua, Onodera, Shiroh, Fulvini, Andrew A, Pokorny, Barbara A, Silverman, Jeanmarie, Devis, Rene, Arroyo, Jennifer M, He, Yu, Boyne, Alex, Bera, Jayati, Halpin, Rebecca, Hine, Erin, Spiro, David J, Bucher, Doris

    Published in PloS one (11-06-2013)
    “…Background Human influenza virus isolates generally grow poorly in embryonated chicken eggs. Hence, gene reassortment of influenza A wild type (wt) viruses is…”
    Get full text
    Journal Article
  12. 12

    Molecular Signature of High Yield (Growth) Influenza A Virus Reassortants Prepared as Candidate Vaccine Seeds. e65955 by Ramanunninair, Manojkumar, Le, Jianhua, Onodera, Shiroh, Fulvini, Andrew A, Pokorny, Barbara A, Silverman, Jeanmarie, Devis, Rene, Arroyo, Jennifer M, He, Yu, Boyne, Alex

    Published in PloS one (01-06-2013)
    “…Background Human influenza virus isolates generally grow poorly in embryonated chicken eggs. Hence, gene reassortment of influenza A wild type (wt) viruses is…”
    Get full text
    Journal Article
  13. 13

    Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humans by Kilbourne, Edwin D., Couch, Robert B., Kasel, Julius A., Keitel, Wendy A., Cate, Thomas R., Quarles, John H., Grajower, Bemardo, Pokorny, Barbara A., Johansson, Bert E.

    Published in Vaccine (1995)
    “…The immunogenicity and toxicity of a purified influenza virus (N2) neuraminidase vaccine (NAV) were investigated in 88 human subjects aged 18–40, and compared…”
    Get full text
    Journal Article